| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50019 |
NIH 3T3 p-7 cl-3 |
mouse |
embryo, whole |
fibroblast (NIH Swiss mouse) |
|
| 2 | general cells |
IFO50026 |
CCRF-SB |
human |
peripheral blood |
Karyotypes appeared normal diploid. This cell line does not synthesize immunogloblins. |
|
| 3 | general cells |
IFO50078 |
IT-26R21 |
rat |
thymus |
T cell differentiation factor producing, (Wistar rat) |
|
| 4 | general cells |
IFO50107 |
G-292 clone A141B1 |
human |
bone |
osteosarcoma |
|
| 5 | general cells |
IFO50269 |
GH1 |
rat |
pituitary gland |
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat) |
|
| 6 | general cells |
IFO50271 |
HUV-EC-C |
human |
umbilical cord, vein |
Normal endothelial cells with limited life span. For cultivation, endothelial cell growth supplement can be substituted by ca 10 ng/ml basic FGF. |
|
| 7 | general cells |
IFO50368 |
no.10 |
human |
brain |
Human anaplastic glioma cell line derived from brain. |
|
| 8 | general cells |
IFO50472 |
MEB5 |
mouse |
brain |
Neural stem cell line established from embryonic 14.5 day mouse cerebrum by E7 oncogene of HPV type 16. Withdrawal of EGF induces apoptosis or differentiation to neurons, astrocytes, and oligodendrocytes. LIF induces differentiation into astrocytes. |
|
| 9 | general cells |
JCRB0016 |
P388-D1 |
mouse |
|
lymphoid neoplasm, derived from P388, (DBA/2 mouse) |
|
| 10 | general cells |
JCRB0116.1 |
U937 cl1-14 |
human |
pleural effusion |
lymphoma, histiocytic, highly susceptible clone of U937 for HIV |
|
| 11 | general cells |
JCRB0118 |
SKM-1 |
human |
peripheral blood |
myelo dysplastic syndrome |
|
| 12 | general cells |
JCRB0129.1 |
RCR-1 |
rat |
brain |
Rat astrocyte-like cells producing GFAP. Serum free cell line (RCR-1.P3) is also available. |
|
| 13 | general cells |
JCRB0132.2 |
AH601.P3(JTC27) |
rat |
acites |
AH-601 cell line adapted to a serum free medium. |
|
| 14 | general cells |
JCRB0138 |
KHM-3S |
human |
pleural effusion |
small cell carcinoma, HTLV-1gene integration |
|
| 15 | general cells |
JCRB0143.6 |
F2408 EBNA2 cl-23 |
rat |
whole body of embryo |
This cell line is one of a series of F2408 rat cell lines with recombinant plasmid pZE2 with coding region of the EBNA2 transfected, but the expression of the EBNA2 was weak in this strain. |
|
| 16 | general cells |
JCRB0194 |
KON |
human |
cervical lymph node |
Human squamous carcinoma cell line from oral floor. |
|
| 17 | general cells |
JCRB0213 |
HeLa AG |
human |
cervix |
epitheloid carcinoma, 8-azaguanine-resistant |
|
| 18 | general cells |
JCRB0214 |
HeLa TG |
human |
cervix |
epitheloid carcinoma, 6-thioguanine-resistant |
|
| 19 | general cells |
JCRB0625 |
Ca9-22 |
human |
gingival |
squamous carcinoma, gingiva |
|
| 20 | general cells |
JCRB0626 |
TG1 |
hamster, Chinese |
lung |
V79 derivative, 6-thioguanine-resistant |
|
| 21 | general cells |
JCRB0813 |
VMRC-RCW |
human |
renal |
renal cell carcinoma |
|
| 22 | general cells |
JCRB1006.1F |
OUMS-36T-1F |
human |
embryo |
fibroblast, immortalized by hTRT, derivative of OUMS-36 |
|
| 23 | general cells |
JCRB1090 |
NCE 16IIA |
human |
cervix |
HPV16 transformed noraml cells derived from human cervix. |
|
| 24 | general cells |
JCRB1182 |
NCC-RbC-51 |
human |
cervical lymph node metastasis |
Human retinoblastoma cell line. The growth is very slow. |
|
| 25 | general cells |
JCRB1213.3 |
DIG104.10H.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against digoxin. |
|
| 26 | general cells |
JCRB1314 |
HPSV178-4-3 |
mouse |
|
Hybridoma cell line producing mAb HPSV178, against the C-terminal portion of PrPSV (residues 214-230). |
|
| 27 | general cells |
JCRB1342.08 |
MOR131.5.13 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 28 | general cells |
JCRB1570 |
H-1D(H162) |
mouse |
bone marrow |
Mouse bone marrow-derived osteoblast-like cell line. |
|
| 29 | general cells |
JCRB1629 |
hTf/CHO-S #17/sf |
hamster, Chinese |
ovary |
This cell line produce human transferrin (cell freezed by 10% DMSO+90%FBS). |
|
| 30 | general cells |
JCRB1814 |
Mutu III |
human |
blood |
Burkitt lymphoma derived B cell line latently infected with EBV (type III latency) |
|
| 31 | general cells |
JCRB1826 |
NALM-24 |
human |
peripheral blood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line.
From the same patient as NALM-25 |
|
| 32 | general cells |
JCRB1868 |
AT/RT |
human |
|
atypical teratoid/rhabdoid tumor |
|
| 33 | general cells |
JCRB1913 |
Me1Tu |
human |
|
Transplanted cell line of malignant pleural mesothelioma TCC-MESO-1 into SCID mice. |
|
| 34 | general cells |
JCRB2223 |
A9(BsrX) |
human chromosome-introduced |
skin |
contains human chromosome X (MTA with Tottori Univ. is required.) |
|
| 35 | general cells |
JCRB4095 |
NCC-TGCT1-C1 |
human |
Left hip |
Cell line derived from tenosynovial giant cell tumor (cell growth is considerably slow) |
|
| 36 | general cells |
JCRB9050 |
IMR-32 |
human |
neuroblastoma arising at abdomen |
Human neuroblastoma cell line. |
|
| 37 | general cells |
JCRB9064 |
LC540 |
rat |
testicular tumor |
Leydig cell testicular tumor |
|
| 38 | general cells |
JCRB9124 |
M.dunni(Clone III8C) |
pygmy mouse |
tail |
normal, support the growth of all 4 classes of MuLV |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.